Abstract: A long-standing autoimmune condition known as rheumatoid arthritis RA leads to ongoing inflammation of the joints, which will eventually result in damage to the joints and loss of mobility. The objective of traditional treatments, including Disease-Modifying Antirheumatic Drugs (DMARDs) and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), is to alleviate signs. However, based on the patient, these options tend to have unpredictable results and detrimental side effects. To find out more about how herbal emulgels can contribute to the treatment of RA, earlier studies were also reviewed. The investigation examined the manufacturing process, physical and chemical properties, release mechanism of active ingredients, and therapeutic performance of various formulations. The primary focus was on emulgels that contained antiinflammatory plants like boswellia (Boswellia serrata), ginger (Zingiber officinale), and turmeric (Curcuma longa). The exploration included ways that incorporating nano- and micro-emulsion technologies could improve the length of skin penetration and medication absorption of active ingredients. With its strong anti-inflammatory and analgesic properties, research ranging from laboratory tests to human trials has proven that herbal emulgels can significantly reduce joint pain, inflammation, and stiffness. As they have fewer side effects, their results tend to be comparable to those of standard therapies. Well-designed emulgels demonstrated improved delivery of active ingredients through the skin, enhanced stability, and ease of application. The incorporation of nano- and micro-emulsions augmented the treatment's absorption in the skin and extended its duration of action. Herbal emulgels represent a convenient and safe option for RA therapy. These preparations enhance the efficacy of the treatment while reducing the risk of side effects by combining advanced delivery methods with the therapeutic properties of medicinal herbs. The data available to date suggest that they may prove to be a helpful adjunct—or even a substitute for existing RA therapies—but more clinical studies would need to be conducted to establish their long-term safety and efficacy.
Sharma et al. (Tue,) studied this question.